These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1374761

  • 41. [Characterization of antigenic types of circulating rotaviruses in Mendoza, Argentina based on typing of the external VP7 capsid protein].
    Espul C, Cuello H, Navarta LM, Mamani N, O'Ryan M, O'Ryan M.
    Acta Gastroenterol Latinoam; 1993; 23(4):211-6. PubMed ID: 8203182
    [Abstract] [Full Text] [Related]

  • 42. Classification of rotavirus VP4 and VP7 serotypes.
    Hoshino Y, Kapikian AZ.
    Arch Virol Suppl; 1996; 12():99-111. PubMed ID: 9015107
    [Abstract] [Full Text] [Related]

  • 43. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
    Ludert JE, Ruiz MC, Hidalgo C, Liprandi F.
    J Virol; 2002 Jul; 76(13):6643-51. PubMed ID: 12050377
    [Abstract] [Full Text] [Related]

  • 44. Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.
    Gorziglia M, Larralde G, Kapikian AZ, Chanock RM.
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7155-9. PubMed ID: 1698292
    [Abstract] [Full Text] [Related]

  • 45. Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion.
    Rimer HC, Wasserman SS, Flores J, Pichichero ME, Losonsky GA.
    J Infect Dis; 1992 May; 165(5):826-30. PubMed ID: 1373753
    [Abstract] [Full Text] [Related]

  • 46. Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins.
    Gorziglia M, Larralde G, Ward RL.
    J Virol; 1990 Sep; 64(9):4534-9. PubMed ID: 1696640
    [Abstract] [Full Text] [Related]

  • 47. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.
    Herrmann JE, Chen SC, Jones DH, Tinsley-Bown A, Fynan EF, Greenberg HB, Farrar GH.
    Virology; 1999 Jun 20; 259(1):148-53. PubMed ID: 10364499
    [Abstract] [Full Text] [Related]

  • 48. Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.
    Yuan L, Honma S, Kim I, Kapikian AZ, Hoshino Y.
    J Infect Dis; 2009 Nov 01; 200(9):1443-51. PubMed ID: 19785527
    [Abstract] [Full Text] [Related]

  • 49. Rotavirus-neutralizing antibodies inhibit virus binding to integrins alpha 2 beta 1 and alpha 4 beta 1.
    Fleming FE, Graham KL, Taniguchi K, Takada Y, Coulson BS.
    Arch Virol; 2007 Nov 01; 152(6):1087-101. PubMed ID: 17318737
    [Abstract] [Full Text] [Related]

  • 50. Efficient production of antigenic mosaic reassortants of rotavirus with the aid of anti-VP4 and anti-VP7 neutralizing monoclonal antibodies.
    Kobayashi N, Taniguchi K, Urasawa T, Urasawa S.
    J Virol Methods; 1993 Sep 01; 44(1):25-34. PubMed ID: 7693744
    [Abstract] [Full Text] [Related]

  • 51. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
    Giammarioli AM, Mackow ER, Fiore L, Greenberg HB, Ruggeri FM.
    Virology; 1996 Nov 01; 225(1):97-110. PubMed ID: 8918537
    [Abstract] [Full Text] [Related]

  • 52. Incidence and prevalence of human group C rotavirus infections in Argentina.
    Castello AA, Argüelles MH, Villegas GA, Olthoff A, Glikmann G.
    J Med Virol; 2002 May 01; 67(1):106-12. PubMed ID: 11920824
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Evaluation on the efficacy and immunogenicity of recombinant DNA plasmids expressing S gene from porcine epidemic diarrhea virus and VP7 gene from porcine rotavirus.
    Yin Y, Zhu L, Liu P, Zhao J, Fan Y, Sun X, Xu Z.
    Braz J Microbiol; 2019 Jan 01; 50(1):279-286. PubMed ID: 30637649
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Cross-reactive, serotype- and monotype-specific neutralization epitopes on VP7 of serotype G3 and G5 porcine rotavirus strains.
    Ciarlet M, Hidalgo M, Liprandi F.
    Arch Virol; 1996 Jan 01; 141(3-4):601-14. PubMed ID: 8645098
    [Abstract] [Full Text] [Related]

  • 57. Protective immunity induced by rotavirus DNA vaccines.
    Chen SC, Fynan EF, Robinson HL, Lu S, Greenberg HB, Santoro JC, Herrmann JE.
    Vaccine; 1997 Jun 01; 15(8):899-902. PubMed ID: 9234543
    [Abstract] [Full Text] [Related]

  • 58. Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children.
    Kobayashi M, Araki K, Thompson J, Tollefson SJ, Wright PF.
    J Infect Dis; 1993 Mar 01; 167(3):748-52. PubMed ID: 8382725
    [Abstract] [Full Text] [Related]

  • 59. Sequence conservation within neutralization epitope regions of VP7 and VP4 proteins of human serotype G4 rotavirus isolates.
    Palombo EA, Bishop RF, Cotton RG.
    Arch Virol; 1993 Mar 01; 133(3-4):323-34. PubMed ID: 7504915
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.